These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


264 related items for PubMed ID: 1677249

  • 1. [Non-sedative antihistaminics and binding to central and peripheral H1 histamine receptors].
    Leysen JE, Gommeren W, Janssen PF, Sanz G, Gillardin JM, Schotte A, Janssen PA.
    Allerg Immunol (Paris); 1991 Feb; 23(2):51-7. PubMed ID: 1677249
    [Abstract] [Full Text] [Related]

  • 2. In vitro and in vivo binding characteristics of a new long-acting histamine H1 antagonist, astemizole.
    Laduron PM, Janssen PF, Gommeren W, Leysen JE.
    Mol Pharmacol; 1982 Mar; 21(2):294-300. PubMed ID: 6124876
    [Abstract] [Full Text] [Related]

  • 3. In vivo and in vitro interaction of the novel selective histamine H1 receptor antagonist mizolastine with H1 receptors in the rodent.
    Benavides J, Schoemaker H, Dana C, Claustre Y, Delahaye M, Prouteau M, Manoury P, Allen J, Scatton B, Langer SZ.
    Arzneimittelforschung; 1995 May; 45(5):551-8. PubMed ID: 7612054
    [Abstract] [Full Text] [Related]

  • 4. Recent advances in H1-receptor antagonist treatment.
    Simons FE.
    J Allergy Clin Immunol; 1990 Dec; 86(6 Pt 2):995-9. PubMed ID: 1979802
    [Abstract] [Full Text] [Related]

  • 5. The comparative pharmacokinetics of H1-receptor antagonists.
    Simons FE, Simons KJ, Chung M, Yeh J.
    Ann Allergy; 1987 Dec; 59(6 Pt 2):20-4. PubMed ID: 2892445
    [Abstract] [Full Text] [Related]

  • 6. Treatment of urticaria and angioedema: low-sedating H1-type antihistamines.
    Soter NA.
    J Am Acad Dermatol; 1991 Jun; 24(6 Pt 2):1084-7. PubMed ID: 1677011
    [Abstract] [Full Text] [Related]

  • 7. Evaluation of the potential cardiotoxicity of the antihistamines terfenadine, astemizole, loratadine, and cetirizine in atopic children.
    Delgado LF, Pferferman A, Solé D, Naspitz CK.
    Ann Allergy Asthma Immunol; 1998 Apr; 80(4):333-7. PubMed ID: 9564984
    [Abstract] [Full Text] [Related]

  • 8. In vitro and in vivo studies of the non-sedating antihistamine epinastine.
    Fügner A, Bechtel WD, Kuhn FJ, Mierau J.
    Arzneimittelforschung; 1988 Oct; 38(10):1446-53. PubMed ID: 2461715
    [Abstract] [Full Text] [Related]

  • 9. Relationship between occupation of cerebral H1-receptors and sedative properties of antihistamines. Assessment in the case of terfenadine.
    Rose C, Quach TT, Llorens C, Schwartz JC.
    Arzneimittelforschung; 1982 Oct; 32(9a):1171-3. PubMed ID: 6129863
    [Abstract] [Full Text] [Related]

  • 10. A double-blind, single-dose, crossover comparison of cetirizine, terfenadine, loratadine, astemizole, and chlorpheniramine versus placebo: suppressive effects on histamine-induced wheals and flares during 24 hours in normal subjects.
    Simons FE, McMillan JL, Simons KJ.
    J Allergy Clin Immunol; 1990 Oct; 86(4 Pt 1):540-7. PubMed ID: 1977781
    [Abstract] [Full Text] [Related]

  • 11. Comparative analysis of the cardiotoxicity proclivities of second generation antihistamines in an experimental model predictive of adverse clinical ECG effects.
    Hey JA, del Prado M, Sherwood J, Kreutner W, Egan RW.
    Arzneimittelforschung; 1996 Feb; 46(2):153-8. PubMed ID: 8720304
    [Abstract] [Full Text] [Related]

  • 12. Pharmacology of antihistamines.
    Woodward JK.
    J Allergy Clin Immunol; 1990 Oct; 86(4 Pt 2):606-12. PubMed ID: 1977782
    [Abstract] [Full Text] [Related]

  • 13. Pharmacological modulation of cutaneous reactivity to histamine: a double-blind acute comparative study between cetirizine, terfenadine and astemizole.
    Ghys L, Rihoux JP.
    J Int Med Res; 1989 Oct; 17(1):24-7. PubMed ID: 2565265
    [Abstract] [Full Text] [Related]

  • 14. Nonsedating histamine H1-receptor antagonists.
    Mann KV, Crowe JP, Tietze KJ.
    Clin Pharm; 1989 May; 8(5):331-44. PubMed ID: 2568212
    [Abstract] [Full Text] [Related]

  • 15. Central effects of fexofenadine and cetirizine: measurement of psychomotor performance, subjective sleepiness, and brain histamine H1-receptor occupancy using 11C-doxepin positron emission tomography.
    Tashiro M, Sakurada Y, Iwabuchi K, Mochizuki H, Kato M, Aoki M, Funaki Y, Itoh M, Iwata R, Wong DF, Yanai K.
    J Clin Pharmacol; 2004 Aug; 44(8):890-900. PubMed ID: 15286093
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Molecular basis for the lack of HERG K+ channel block-related cardiotoxicity by the H1 receptor blocker cetirizine compared with other second-generation antihistamines.
    Taglialatela M, Pannaccione A, Castaldo P, Giorgio G, Zhou Z, January CT, Genovese A, Marone G, Annunziato L.
    Mol Pharmacol; 1998 Jul; 54(1):113-21. PubMed ID: 9658196
    [Abstract] [Full Text] [Related]

  • 18. Pharmacokinetic overview of oral second-generation H1 antihistamines.
    González MA, Estes KS.
    Int J Clin Pharmacol Ther; 1998 May; 36(5):292-300. PubMed ID: 9629995
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 14.